glutathione and triple negative breast cancer Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven metalloimmunotherapy for triple-negative | Journal of Nanobiotechnology Ferroptosis heterogeneity in triple-negative breast
Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism Oncology Letters A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Metabolic reprogramming in triple negative breast cancer Cancer Biology & Medicine
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31




